Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Chiesi Farmaceutici S.p.A.

This publication has 52 references indexed in Scilit: